AccomplishmentsKey Opioid Settlements
Attorney General Tong is a national leader in efforts to hold the addiction industry accountable for the devastation of the opioid epidemic, delivering more than $40 billion to states nationwide. This work has just begun.
Purdue Pharma and the Sacklers
Attorney General Tong announced last March that Purdue Pharma and the Sackler family will pay $6 billion to victims, survivors, and states for their role in the opioid epidemic. Connecticut will receive up to $95 million to support opioid treatment and prevention, and provide aid to victims and survivors. Attorney General Tong led the small coalition of dissenting states that refused to settle early, forcing billions of dollars more from Purdue and the Sacklers.
Distributors and Johnson & Johnson
In July 2021, Attorney General Tong announced an historic $26 billion agreement with pharmaceutical distributors Cardinal, McKesson, and AmerisourceBergen and manufacturer Johnson & Johnson to bring desperately needed resources to fight the opioid crisis. Connecticut will receive approximately $300 million as part of the landmark settlement. The first $11 million payment to Connecticut and its cities and towns arrived this month. Attorney General Tong led a coalition rejecting an earlier settlement plan, pushing the total figure from $19 billion up to $26 billion.
In February 2021, Attorney General Tong announced Connecticut had helped lead a coalition of attorneys general from 47 states, the District of Columbia and five U.S. territories in a $573 million settlement with McKinsey & Company. Connecticut will receive $7,513,087.22, which will be used to abate the opioid epidemic.
In October 2020, Attorney General Tong announced a $1.6 billion global settlement framework had been reached between state attorneys general and opioid manufacturer Mallinckrodt. The company has since declared bankruptcy. Connecticut will receive $13.9 million.
In July 2022, Attorney General Tong announced a $2.37 billion agreement framework with Allergan and states regarding the generic drug manufacturer’s role in the opioid epidemic.
In July 2022, Attorney General Tong announced a $4.25 billion agreement framework with Teva Pharmaceuticals and states regarding the generic drug manufacturer’s role in the opioid epidemic.
In August 2022, Attorney General Tong announced an agreement in principle with opioid maker Endo International and its lenders that would provide up to $450 million to participating states and local governments, ban promotion of Endo’s opioids, and require Endo to turn over millions of documents related to its role in the opioid crisis for publication in a public online archive.